Open access · US-GOV via ClinicalTrials.gov Clinical trial

Ultra-high Field Multimodal and Multinuclear Neuroimaging Cohort Study of Alzheimer's Disease

Authors not listed

Chinese PLA General Hospital · 2025

Loss of proteostasis Human Randomized controlled trial Cohort study

Abstract

This single-center prospective cohort study will enroll 750 participants (250 cognitively Normal (CN) individuals, 250 with mild cognitive impairment (MCI), and 250 with Alzheimer's disease (AD)). At baseline and at annual follow-ups, participants will undergo 3 Tesla (3 T) and 7 Tesla (7 T) multimodal magnetic resonance imaging (MRI) scans, blood biomarker testing, genotyping, and cognitive assessments to identify early imaging biomarkers and construct models of disease progression.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-10-26 MST

Cite this

APA

Anonymous. (2025). Ultra-high Field Multimodal and Multinuclear Neuroimaging Cohort Study of Alzheimer's Disease. <em>Chinese PLA General Hospital</em>. https://clinicaltrials.gov/study/NCT07089303

Vancouver

Anonymous. Ultra-high Field Multimodal and Multinuclear Neuroimaging Cohort Study of Alzheimer's Disease. Chinese PLA General Hospital. 2025.

BibTeX

@misc{anon2025Ultrah, title = {Ultra-high Field Multimodal and Multinuclear Neuroimaging Cohort Study of Alzheimer's Disease}, author = {Anonymous}, journal = {Chinese PLA General Hospital}, year = {2025}, }